Proposed Special Review Decision PSRD2021-01, Special review for Iprodione and its associated end-use products

Before making a final decision on the special review of iprodione, Health Canada will consider all comments received from the public in response to this consultation document. Health Canada will then publish a special review decision document, which will include the decision, the reasons for it, a summary of the comments received on the proposed decision, and Health Canada's response to these comments.

Publisher

Health Canada

Resources

2

Catalogue metadata updated

2023-05-31